Lipinz is the trade name and generic name of Fenofibrate Capsules. Fenofibrate capsules are effective in lowering blood lipids and are mainly used to treat hypercholesterolemia and/or hypertriglyceridemia in adult patients who are not satisfactorily treated by dietary control. Side effects of fenofibrate capsules are generally mostly reversible after discontinuation of the drug, including muscle dysfunction and, rarely, severe rhabdomyolysis. A few patients may experience gastrointestinal digestive dysfunction and allergic skin reactions. In addition, it is prohibited for patients who are allergic to the drug components in Fenofibrate capsules, prohibited for patients with hepatic or renal insufficiency, prohibited for use in combination with other beta drugs, not recommended for use in combination with HMG-CoA reductase inhibitors, prohibited for use in children, and prohibited for use in pregnant women and breastfeeding women. If you need to use Fenofibrate capsules, it is recommended to consult a professional doctor, follow the doctor’s instructions for standardized treatment, not blindly self-medication.